furosemide has been researched along with prazosin in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (34.55) | 18.7374 |
1990's | 9 (16.36) | 18.2507 |
2000's | 14 (25.45) | 29.6817 |
2010's | 12 (21.82) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
Caron, G; Ermondi, G; Lorenti, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Riddiough, MA | 1 |
Atwell, RB | 1 |
Guerricchio, G; Scandiffo, T; Veglia, L | 1 |
Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT | 1 |
Kawasaki, H; Nakamura, S; Takasaki, K | 1 |
Abildgaard, U; Christensen, S; Petersen, JS; Shalmi, M | 1 |
Gŭrchev, R; Pir'ova, B | 1 |
Liedtke, CM | 1 |
Baricevic, K; Darley, P; Guittard, G; Place, V; Pruitt, B; Ramans, A | 1 |
Fulton, JD; Leckie, BJ; Malatino, LS; McAreavey, D; Morton, JJ; Murray, GD; Robertson, JI; Webb, DJ | 1 |
Braun, L; Colucci, R; Guzman, NJ; Kelly, RA; Loon, NR; Maroni, BJ; Mitch, WE; Rayment, CM; Souney, PF; Wilcox, CS | 1 |
De Soignie, R; Sellin, JH | 1 |
Fischer, E; Siegenthaler, W | 1 |
Silke, B; Taylor, SH | 1 |
Frishman, W; Kugler, J; LeJemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
Bartay, J; Benson, D; Peterson, LG | 1 |
Gattringer, K; Judmaier, G; Kunz, F; Mikuz, G; Zwierzina, WD | 1 |
Jørgensen, F; Nielsen, PE | 1 |
Ishikawa, T; Koiwaya, Y; Kondoh, H; Nakagawa, S; Tanaka, K | 1 |
Gale, EV; Kuan, P; Reuben, SR; Wilde, PM | 1 |
Berkowitz, RL | 1 |
Fantini, F; Franchi, F; Michelucci, A; Morace, G; Porciani, MC | 1 |
Albillos, A; Bañares, R; Bosch, J; Escartín, P; Garrido, A; Iborra, J; Lledó, JL; Pérez-Páramo, M; Rossi, I; Tabuenca, MJ | 1 |
Elliott, WJ | 1 |
Karlberg, BE; Kron, BG; Odlind, BG; Sjöström, PA | 1 |
Choy, AM; Lang, CC; Rahman, AR; Struthers, AD | 1 |
Kron, BG; Odlind, BG; Sjöström, PA | 1 |
Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
Gokee, A; Rocchini, AP; Yang, JQ | 1 |
Braun, U; Poon, IO | 1 |
Albarran, HA; Rodriguez, GC; Zeron, HM | 1 |
Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM | 1 |
3 review(s) available for furosemide and prazosin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone | 1977 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Infant Mortality; Methyldopa; Nitroprusside; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Secologanin Tryptamine Alkaloids; Sodium; Sodium Chloride Symporter Inhibitors | 1980 |
5 trial(s) available for furosemide and prazosin
Article | Year |
---|---|
Human buccal assay for evaluation of the mucosal irritation potential of drugs.
Topics: Administration, Topical; Adult; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Female; Furosemide; Gels; Humans; Male; Methyldopa; Middle Aged; Mouth Mucosa; Prazosin; Prognosis; Propranolol; Time Factors | 1988 |
Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Epinephrine; Female; Furosemide; Heart Rate; Homeostasis; Humans; Kinetics; Male; Norepinephrine; Potassium; Prazosin; Reference Values; Renin; Sodium | 1987 |
Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Blood Pressure; Female; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Portal; Kidney; Liver; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Portal System; Prazosin; Propranolol; Renin; Vascular Resistance; Venous Pressure | 1995 |
Acute tolerance to furosemide. Pretreatment with captopril or prazosin does not influence diuresis and natriuresis.
Topics: Adult; Aldosterone; Angiotensin II; Captopril; Dehydration; Diuresis; Drug Tolerance; Furosemide; Glomerular Filtration Rate; Humans; Male; Natriuresis; Osmolar Concentration; Prazosin; Regression Analysis; Renin; Sodium; Time Factors | 1994 |
Renal effects of low dose prazosin in patients with congestive heart failure.
Topics: Aged; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Middle Aged; Prazosin; Single-Blind Method; Sodium; Vascular Resistance | 1993 |
47 other study(ies) available for furosemide and prazosin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
Topics: Chromatography, Affinity; Hydrogen-Ion Concentration; Ions; Models, Molecular; Molecular Conformation; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Serum Albumin, Bovine; Ultracentrifugation | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insufficiency; Prazosin; Quinazolines | 1979 |
[Echocardiographic changes in severe congestive heart failure treated with prazosin].
Topics: Aged; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; Medigoxin; Middle Aged; Prazosin; Quinazolines | 1979 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine; Nitroprusside; Prazosin; Quinazolines; Sodium; Tachycardia | 1978 |
Central alpha 2-adrenoceptor-mediated pressor response to clonidine in conscious, spontaneously hypertensive rats.
Topics: Anesthesia; Animals; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Furosemide; Heart Rate; Hypertension; Injections, Intraventricular; Male; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Water Deprivation; Yohimbine | 1992 |
Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Drug Interactions; Female; Furosemide; Infusions, Intravenous; Kidney Function Tests; Kidney Tubules, Proximal; Lithium; Prazosin; Rats; Rats, Inbred Strains; Sodium | 1991 |
[The effect of using furosemide in selective adrenergic alpha 1-receptor stimulation and alpha 1-receptor blockade].
Topics: Animals; Diuresis; Drug Interactions; Furosemide; Kidney; Male; Methoxamine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1990 |
Alpha-adrenergic regulation of Na-Cl cotransport in human airway epithelium.
Topics: Carrier Proteins; Chlorides; Cystic Fibrosis; Epinephrine; Epithelium; Furosemide; Humans; Intracellular Fluid; Isoproterenol; Kinetics; Methoxamine; Nasal Polyps; Prazosin; Receptors, Adrenergic, alpha; Sodium Chloride Symporters; Symporters; Trachea | 1989 |
The effect of chronic prazosin therapy on the response of the renin-angiotensin system in patients with essential hypertension.
Topics: Adult; Blood Pressure; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Posture; Prazosin; Renin-Angiotensin System | 1987 |
Regulation of Na-Cl absorption in rabbit proximal colon in vitro.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Animals; Bumetanide; Colon; Epinephrine; Furosemide; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Prazosin; Propranolol; Rabbits; Sodium Chloride; Yohimbine | 1987 |
[Vasodilators in heart failure? Basic principles and its role in practice].
Topics: Adrenergic alpha-Antagonists; Captopril; Diazoxide; Furosemide; Heart Failure; Humans; Hydralazine; Minoxidil; Phentolamine; Prazosin; Vasodilator Agents | 1981 |
The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Digoxin; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Prazosin; Proline; Vasodilator Agents | 1982 |
Neuropsychiatric manifestations of antihypertensive medications.
Topics: Adrenergic beta-Antagonists; Affective Symptoms; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Prazosin; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors | 1983 |
[Acute fatty liver in pregnancy with consumption coagulopathy].
Topics: Acute Disease; Adult; Ampicillin; Ascites; Disseminated Intravascular Coagulation; Electrolytes; Fatty Liver; Female; Furosemide; Glucose; Humans; Laparoscopy; Prazosin; Pregnancy; Pregnancy Complications | 1983 |
An unusual young male with exercise induced, severe hypertensive spikes. What's the diagnosis?
Topics: Adult; Drug Therapy, Combination; Furosemide; Humans; Hypertension; Male; Minoxidil; Physical Exertion; Prazosin; Propranolol | 1983 |
Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone.
Topics: Adult; Cardiomyopathies; Digitalis Glycosides; Electrocardiography; Female; Furosemide; Heart Ventricles; Humans; Myocardial Contraction; Prazosin; Prednisolone; Sarcoidosis | 1984 |
Haemodynamic effects of prazosin in CHF.
Topics: Cardiac Catheterization; Cardiac Output; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines | 1981 |
[Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
Topics: Adult; Aged; Digoxin; Drug Evaluation; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1980 |
An individualized approach to the hypertensive patient with renal disease: six illustrative case studies.
Topics: Adrenergic alpha-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Auscultation; Benzothiadiazines; Cough; Diabetes Mellitus, Type 1; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Minoxidil; Prazosin; Proteinuria; Sodium Chloride Symporter Inhibitors; Verapamil | 1995 |
Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration.
Topics: Adult; Captopril; Furosemide; Humans; Kidney; Male; Metabolic Clearance Rate; Prazosin; Premedication; Protein Binding; Renal Circulation; Serum Albumin | 1993 |
Alpha2-adrenoceptors mediate the effect of dopamine on adult rat jejunal electrolyte transport.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiloride; Animals; Brimonidine Tartrate; Bucladesine; Cardiotonic Agents; Colforsin; Diuretics; Dopamine; Dose-Response Relationship, Drug; Electric Impedance; Electrolytes; Furosemide; Ion Transport; Jejunum; Male; Ouabain; Phentolamine; Prazosin; Propranolol; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2 | 1998 |
Hypertension and insulin resistance are not directly related in obese dogs.
Topics: Adrenergic beta-Antagonists; Animals; Aspirin; Atenolol; Blood Glucose; Clonidine; Diet, Sodium-Restricted; Dietary Fats; Dogs; Female; Furosemide; Hemodynamics; Hypertension; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Models, Animal; Models, Biological; Obesity; Prazosin; Protein Serine-Threonine Kinases; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathetic Nervous System | 2004 |
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Drug Therapy; Female; Furosemide; Health Services for the Aged; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypotension, Orthostatic; Lisinopril; Male; Outpatients; Patient Selection; Prazosin; Prevalence; Retrospective Studies; Veterans | 2005 |
Hemodynamic evaluation and anti-hypertensive schemes used in puerperal women following pre-eclampsia.
Topics: Adolescent; Adult; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Catheterization, Swan-Ganz; Drug Therapy, Combination; Eclampsia; Electric Impedance; Female; Furosemide; Hemodynamics; Humans; Nitroprusside; Postpartum Period; Prazosin; Pre-Eclampsia; Pregnancy; Telmisartan; Young Adult | 2012 |
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan | 2020 |